The pitch arrived the way most pitches do: clean, confident, and missing the part that matters. EQX Labs — an entity I had not previously audited — is issuing tokenized US equities on Hyperliquid through the chain's native HIP-1 standard. Twenty-four-seven trading. Permissionless access. No fees on creation, redemption, or holding. Eleven markets, "coming soon."
Then I found the adjective. Dividend distribution, the release promises, will flow "directly to holders" once a "proposed HIP-1 extension" goes live. Proposed. Not deployed. Not audited. Not scheduled. The headline yield feature of a product marketed as a tokenized stock depends on infrastructure that does not exist yet. Audit the code, not the pitch — and here, the code has not been written.
That single word is not a fatal flaw on its own. It is a signal. And in the business of tokenized securities, the signals are the product.
The Landscape EQX Is Walking Into
Tokenized equities are not a new idea, and Hyperliquid is not the first place to try them. Backed Finance has been issuing xStocks as ERC-20 and SPL tokens for years, with listings across Kraken and Solana. Ondo Finance built its franchise on tokenized treasuries and is extending into equities. Dinari has pursued a US-regulated path with dShares. Robinhood EU ships tokenized stocks to retail with the distribution muscle of a legacy brokerage. Each of them arrived before EQX, and each has a clearer story about compliance.
Against that field, EQX is a latecomer. Its differentiation is not the asset — a tokenized share of Apple is a tokenized share of Apple — and it is not compliance, where the incumbents are further along. Its differentiation is the venue. EQX chose Hyperliquid.
That choice matters more than the marketing admits. Hyperliquid has spent the past two years converting itself from a perpetuals venue into a full trading platform, and its on-chain order book is the closest thing crypto has to a real exchange matching engine. Most RWA projects mint on general-purpose chains, usually Ethereum or Solana, as ERC-20 or SPL tokens. EQX instead issues natively on HyperCore, Hyperliquid's execution layer, using HIP-1 — the chain's permissionless spot token standard. The practical consequence is that EQX tokens inherit Hyperliquid's public order book rather than bootstrapping liquidity on a separate DEX. In theory, that means immediate access to the venue's existing traders and market-making depth.
Hyperliquid's design also inverts the usual fee relationship. Where a normal L1 charges gas and keeps it, Hyperliquid splits trading fees between the protocol and the HIP-1 deployer. That is the model EQX is betting on: not charging users a cent, and instead earning a cut of trading volume. It is a Web2 playbook — subsidize the friction away, monetize the flow — transplanted onto a chain.
The structure beneath all of this is worth stating plainly before the teardown. EQX Labs is not the issuer. The issuing entity, EQX SPC Ltd., is held by the EQX STAR Trust in the Cayman Islands, and the company operates as a BVI segregated portfolio company. Underneath the tokens sit US equities custodied by three DTC-connected providers: Alpaca, StoneX, and Clear Street. Each token is a limited-recourse note backed one-to-one by a specific portfolio.
That is the machine. Now let me take it apart.
The Settlement Gap Nobody Is Pricing
Start with the mechanism that most cleanly exposes the contradiction: the "in transit" flag. When EQX receives an order, the underlying share is not instantly in the vault. It settles on the next US business day. During that window, the token shows as "in transit" — a placeholder for a share that has been bought but not delivered.
Read that again, because it is the whole ballgame. The token is tradable 24/7, but the asset backing it settles on a T+1 schedule that stops on weekends and US holidays. For a meaningful fraction of every week, the on-chain instrument and its off-chain collateral are out of sync. The chain never sleeps; the DTC does.
This is not a rounding error. It is a structural mismatch between two settlement regimes, and it creates a window in which the 1:1 backing is asserted rather than verifiable. What rights does an "in transit" holder actually have? Who bears the counterparty risk if the purchase fails to settle? The release does not say. Sharding is easy; consensus is hard — and reconciling an always-on ledger with a five-day-a-week clearing system is the consensus problem of RWA, not the token mint.
The second technical tell is subtler. EQX's full feature set — voting, dividends, stock splits — is described as arriving with the "proposed HIP-1 extension." That phrasing means the current HIP-1 standard does not natively support corporate actions. EQX is therefore shipping a product whose differentiation is partly a promise, and whose roadmap depends on a third party delivering an upgrade on an unspecified timeline. That is technical debt masquerading as a feature list.
Consider what this means in practice. A stock split is not an edge case; it is a routine event for large-cap equities. If the standard cannot handle a split natively, then either EQX processes it off-chain through manual intervention, or holders wake up holding a claim whose unit count no longer matches the underlying. Neither is acceptable for something marketed as a stock. The corporate-action layer is exactly where a tokenized equity either works or quietly breaks.
The third tell is the one that should end most conversations: there is no mention of a smart contract audit anywhere in the release. For a product that custodies real equities and mints tradable claims against them, the absence of a published audit is not a minor omission. It is the difference between a system you can verify and a system you must trust. Trust no one, verify everything — and EQX has given us nothing to verify.
The Missing Disclosure
I want to be precise about what is absent, because the pattern matters more than any single gap.
There is no founding team named. No technical lead. No engineering background. There is no disclosed funding round, no investors, no valuation, no backers. For a project that will hold US equities on behalf of strangers, the release tells you nothing about who is behind it. That is not a stylistic choice; it is an information vacuum in exactly the place where information matters most.
The governance structure compounds it. EQX Labs does not own the issuing entity; the Cayman trust does. On paper, that is risk isolation — the operator cannot simply drain the vault. In practice, it means the people running the product may not be the people legally responsible for it. When the entity that mints the token and the entity that holds the assets are different, "who is accountable" becomes a question with no clean answer. That ambiguity is rarely accidental. Complexity hides risk, and a trust layered over an SPC layered over three custodians is a great deal of complexity for a product sold as "just a stock."
The voting mechanism deserves the same skepticism. Holders can, per the release, submit voting instructions via on-chain signatures. But the release does not say whether those votes are binding or advisory. Tokenized equity voting almost always routes through the issuer as proxy, which means the holder's "vote" is a suggestion the issuer may or may not honor. Symbolic governance dressed as shareholder rights is a familiar pattern, and EQX has not distinguished itself from it.
The Economics of Free
The tokenomics here are deliberately unusual, and the usual frameworks do not apply. EQX tokens are not governance tokens, not utility tokens, and not inflationary. They are limited-recourse notes with elastic supply: mint on subscription, burn on redemption, one-for-one with the underlying. There is no team allocation, no vesting cliff, no treasury, no staking APR. The supply simply tracks demand.
What that removes is the standard rug risk. There is no insider unlock waiting to dump on retail, because there are no insider tokens. The value of an EQX note is the value of the share behind it plus any dividend — not protocol revenue shared with holders. In that narrow sense, EQX is cleaner than most of the sector.
What it introduces is a different problem. The issuer earns nothing from users and everything from volume. Creation, redemption, and holding are free. The only revenue is the deployer's share of Hyperliquid trading fees. That means the entire business model is a wager on liquidity: if the eleven markets trade thin, EQX earns nothing and subsidizes the operation out of pocket. Zero-fee models are elegant in a bull market and lethal in a quiet one.
There is also a clause buried in the structure that deserves more attention than it will get: limited recourse. Each token maps to a segregated portfolio, and holders have recourse only to that portfolio's assets — not to EQX SPC Ltd. as a whole. This is the classic SPC bankruptcy-remoteness design, and it cuts both ways. It isolates one portfolio's failure from the others. It also means that if the issuer-level machinery breaks — custody, operations, the trust itself — a holder's claim is confined to their slice.
And the concentration on the custodial side is real. Three DTC-connected providers — Alpaca, StoneX, Clear Street — stand between the tokens and the shares. That is a short list. Any one of them hitting an operational snag or a regulatory wall takes a piece of the backing with it, and because the custodians are US entities touching US securities, they are precisely the chokepoint a US regulator would use.
The Regulatory Room With No Exit
Here is where the structure stops being clever and starts being dangerous.
Run EQX tokens through the Howey test. Money invested: yes. Common enterprise: yes, a one-to-one pooled portfolio. Expectation of profit: yes — price appreciation plus reinvested dividends. Efforts of others: partly, since dividends, splits, and custody all depend on the issuer. That is a security in most jurisdictions, and no amount of calling it a "note" changes the analysis. Renaming a stock a note is the oldest trick in the offshore structuring handbook, and it has never survived contact with a determined regulator.
Now layer on the venue. Hyperliquid is a permissionless derivatives and spot platform with no KYC at the trading layer. Securities law, by contrast, is built on KYC, suitability, and licensed intermediation. EQX is attempting to sell a security-class instrument through a rail that is structurally incapable of the compliance a security requires. Those two facts cannot both be true indefinitely. Either the trading layer gets gated, or the instrument gets reclassified.
The offshore scaffolding reinforces the concern rather than resolving it. A BVI SPC issuing through a Cayman STAR Trust, custodied by US entities connected to the DTC, sold to a global user base on a borderless chain — every layer is chosen to sit outside a single regulator's easy reach. But the custodians are American, the underlying assets are American, and the reach of US securities law is long. The same DTC connection that makes the backing real is the thread a regulator can pull.
The most likely near-term outcome is not enforcement but geofencing. Tokenized-securities projects routinely block US and often EU users to avoid the worst of the exposure, and EQX has said nothing about whether it will. If it does geofence, the "permissionless" pitch is hollow for exactly the users with the money to move markets. If it does not, it is inviting the fight. Either way, the marketing and the law are on a collision course.
What the Bulls Actually Get Right
I have spent most of this piece taking EQX apart, so let me be fair about what survives the teardown.
The L1-native issuance choice is genuinely interesting, and it is the part of this I would defend. Issuing on HyperCore instead of as an ERC-20 is not cosmetic. It plugs a new asset class directly into an existing order book, which sidesteps the cold-start liquidity problem that kills most tokenized-asset launches. If Hyperliquid's traders adopt these markets, EQX gets distribution that no amount of marketing could buy. That is a real structural advantage, and the incumbents issuing on general-purpose chains do not have it.
The 24/7 trading claim is also real, even if it is not unique. It is table stakes for the category, but it is a genuine improvement over the T+1 reality of a brokerage account, and it is the kind of thing that quietly changes user behavior over years rather than quarters. The settlement gap I flagged earlier is the price of that feature, but the feature itself is not fake.
And the fee structure deserves credit for alignment. By taking no user fees and earning only on volume, EQX has aligned its incentives with liquidity rather than extraction. Most projects in this space charge on the way in and the way out; EQX charges on neither. That is a healthier design, and it should be said plainly.
The Verdict
EQX is not vaporware in the way most vaporware is vaporware. There is a real structure, real custodians, and a real venue. What there is not is verification. No audit. No disclosed team. No disclosed funding. Every fact in the release traces back to the release itself.
The pattern to watch is not the token — EQX has none to trade. The pattern to watch is whether Hyperliquid becomes the default venue for tokenized securities, and whether its permissionless trading layer can survive a regulator's attention. If the first batch of eleven markets trades thin, the zero-fee model collapses quietly. If they trade deep, EQX has found something real. Either way, the answer will not come from a press release. It will come from the order book — and from whoever decides, in Washington or Brussels, that a stock wearing a note's clothing is still a stock.